Even if emergence of NF1 mutations following targeted therapies was previously described in melanoma, and the downregulation of NF1 expression was observed in EGFR‐mutated lung adenocarcinoma,31, 32 we do not confirm this observation in our cohort. This evidence concerns the gene EGFR and lung adenocarcinoma.